Adjuvant Therapy in Pancreatic Cancer Helmut OettlePeter Neuhaus Current Opinion 14 September 2012 Pages: 2293 - 2310
Hormone Therapy for the Prevention of Bone Loss in Menopausal Women with Osteopenia Mary H. HohenhausKelly A. McGarryNananda F. Col Current Opinion 14 September 2012 Pages: 2311 - 2321
Pathophysiology and Management of Opioid-Induced Pruritus Arjunan GaneshLynne G. Maxwell Therapy In Practice 14 September 2012 Pages: 2323 - 2333
Estrogen Receptor Modulators and Down Regulators Christa K. BaumannMonica Castiglione-Gertsch Review Article 14 September 2012 Pages: 2335 - 2353
Multidrug-Resistant Streptococcus pneumoniae Infections Françoise Van BambekeRené R. ReinertWilly E. Peetermans Review Article 14 September 2012 Pages: 2355 - 2382
Salmeterol/Fluticasone Propionate Gillian M. KeatingPaul L. McCormack Adis Drug Evaluation 14 September 2012 Pages: 2383 - 2405
Budesonide/Formoterol Paul L. McCormackKatherine A. Lyseng-Williamson Adis Drug Evaluation 14 September 2012 Pages: 2407 - 2431
Celecoxib James E. FramptonGillian M. Keating Adis Drug Evaluation 14 September 2012 Pages: 2433 - 2474
Continuous-Use Ethinylestradiol/Levonorgestrel 20μg/90μg Antona J. Wagstaff Adis Drug Profile 14 September 2012 Pages: 2475 - 2479
Continuous-Use Ethinylestradiol/Levonorgestrel 20µg/90µg as an Oral Contraceptive Paula Bednarek Adis Drug Profile 14 September 2012 Pages: 2480 - 2480
Continuous-Use Ethinylestradiol/Levonorgestrel 20µg/90µg as an Oral Contraceptive Camelia Davtyan Adis Drug Profile 14 September 2012 Pages: 2480 - 2481